Mitsuru Yanagaki

421 total citations
48 papers, 261 citations indexed

About

Mitsuru Yanagaki is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, Mitsuru Yanagaki has authored 48 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 26 papers in Surgery and 17 papers in Hepatology. Recurrent topics in Mitsuru Yanagaki's work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Inflammatory Biomarkers in Disease Prognosis (12 papers). Mitsuru Yanagaki is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Pancreatic and Hepatic Oncology Research (14 papers) and Inflammatory Biomarkers in Disease Prognosis (12 papers). Mitsuru Yanagaki collaborates with scholars based in Japan, United Kingdom and United States. Mitsuru Yanagaki's co-authors include Kenei Furukawa, Toru Ikegami, Koichiro Haruki, Tomohiko Taniai, Shinji Onda, Yoshihiro Shirai, Masashi Tsunematsu, Jungo Yasuda, Ryoga Hamura and Takeshi Gocho and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Oncology and Carcinogenesis.

In The Last Decade

Mitsuru Yanagaki

36 papers receiving 260 citations

Peers

Countries citing papers authored by Mitsuru Yanagaki

Since Specialization

Citations

This map shows the geographic impact of Mitsuru Yanagaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuru Yanagaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuru Yanagaki more than expected).

Fields of papers citing papers by Mitsuru Yanagaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuru Yanagaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuru Yanagaki. The network helps show where Mitsuru Yanagaki may publish in the future.

Co-authorship network of co-authors of Mitsuru Yanagaki

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuru Yanagaki. A scholar is included among the top collaborators of Mitsuru Yanagaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuru Yanagaki. Mitsuru Yanagaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ASO Visual Abstract: ARID4B Promotes the Progression of Hepatocellular Carcinoma Through the PI3K/AKT Pathway 2025 ·Annals of Surgical Oncology ·(unknown), Mitsuru Yanagaki, (unknown), Koichiro Haruki, (unknown), Tomohiko Taniai, Shinji Onda, Ryoga Hamura, Masashi Tsunematsu, Yoshihiro Shirai, Michinori Matsumoto, Masayuki Shimoda, Toru Ikegami	0
2	Simple definition of biologically borderline resectable colorectal liver metastases based on early surgical failure 2025 ·International Journal of Clinical Oncology ·(unknown), Masashi Tsunematsu, Koichiro Haruki, Shinji Onda, (unknown), Michinori Matsumoto, Tomohiko Taniai, Mitsuru Yanagaki, Yoichi Toyama, Toru Ikegami	0
3	Immunological and prognostic significance of vessels encapsulating tumor clusters (VETC) in hepatocellular carcinoma 2025 ·European Journal of Surgical Oncology ·Tomohiko Taniai, Koichiro Haruki, Juha P. Väyrynen, (unknown), Shun Sato, Kenei Furukawa, Masashi Tsunematsu, Mitsuru Yanagaki, Yoshihiro Shirai, Toru Ikegami	0
4	404P Real-world analysis on molecular targeted therapy recommendations and attainment rates in cancer gene panel testing for metastatic breast cancer 2024 ·Annals of Oncology ·Hiroshi Tada, Minoru Miyashita, (unknown), Yohei Hamanaka, Akiko Ebata, Mari Sato, (unknown), Mitsuru Yanagaki, Akira Yamazaki, T. Kon, Takashi Ishida	1
5	Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer 2023 ·Surgical Oncology ·Yoshihiro Shirai, Shinji Onda, (unknown), Ryoga Hamura, Michinori Matsumoto, Mitsuru Yanagaki, Masashi Tsunematsu, Tomohiko Taniai, (unknown), Kenei Furukawa, (unknown), Taro Sakamoto, Takeshi Gocho, Tadashi Uwagawa, Toru Ikegami	1
6	Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study 2023 ·Cancer Discovery ·Takafumi Koyama, Toshio Shimizu, Yuki Kojima, Kazuki Sudo, Hitomi Sumiyoshi Okuma, Tatsunori Shimoi, Hitoshi Ichikawa, Shinji Kohsaka, Ryo Sadachi, Akihiro Hirakawa, Akihiko Yoshida, (unknown), Toshihide Ueno, Mitsuru Yanagaki, (unknown), Kenichi Nakamura, Noboru Yamamoto, Kan Yonemori	25
7	The Japanese 5-5-500 Rule Predicts Prognosis of Hepatocellular Carcinoma After Hepatic Resection 2023 ·Anticancer Research ·(unknown), Koichiro Haruki, Tomohiko Taniai, Kenei Furukawa, Takashi Horiuchi, Shinji Onda, Mitsuru Yanagaki, Yoshihiro Shirai, Ryoga Hamura, Toru Ikegami	3
8	A case of urinary bladder metastasis of hepatocellular carcinoma following use of immunotherapy/tyrosine kinase inhibitor 2023 ·IJU Case Reports ·(unknown), Fumihiko Urabe, Shunsuke Tsuzuki, Shun Sato, Hiroyuki Takahashi, Koji Asano, Mitsuru Yanagaki, Michinori Matsumoto, Toru Ikegami, Takahiro Kimura	0
9	Double cone-unit laparoscopic hepatic resection for tumors adjacent to the hepatic vein 2023 ·Surgical Oncology ·Jungo Yasuda, Kenei Furukawa, Mitsuru Yanagaki, (unknown), (unknown), (unknown), Shinji Onda, Toru Ikegami	0
10	Zero Mortality in Living-Donor Liver Transplantation for Primary Biliary Cholangitis in Patients With a Meld Score of <20 2023 ·Transplantation Proceedings ·Mitsuru Yanagaki, Shinji Onda, Kenei Furukawa, Tomohiko Taniai, Koichiro Haruki, (unknown), Yoshihiro Shirai, Michinori Matsumoto, Takeshi Gocho, Tadashi Uwagawa, Toru Ikegami	0
11	High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer 2022 ·Molecular Cancer Therapeutics ·(unknown), Masachika Ikegami, Takafumi Koyama, Kuniko Sunami, Dai Ogata, Hidenori Kage, Mitsuru Yanagaki, Hiroshi Ikeuchi, Toshihide Ueno, Michihiro Tanikawa, Katsutoshi Oda, Yutaka Osuga, Hiroyuki Mano, Shinji Kohsaka	15
12	The impact of postoperative exocrine index on non‐alcoholic fatty liver disease following pancreaticoduodenectomy 2022 ·Annals of Gastroenterological Surgery ·Masashi Tsunematsu, Takeshi Gocho, Mitsuru Yanagaki, Yoshihiro Shirai, Koichiro Haruki, Kenei Furukawa, Jungo Yasuda, Shinji Onda, Taro Sakamoto, Toru Ikegami	6
13	The time-dependent changes in serum carcinoembryonic antigen impact on posthepatectomy outcomes of colorectal liver metastasis 2022 ·Surgery ·(unknown), Takafumi Nakano, Mitsuru Yanagaki, (unknown), (unknown), Kenei Furukawa, Shinji Onda, (unknown), Toru Ikegami, Ken Eto	2
14	The impact of S-1 for the patient with lymph nodal metastasis biliary tract cancer as adjuvant chemotherapy: a multicenter database analysis 2022 ·International Journal of Clinical Oncology ·Ryoga Hamura, Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, Yoshihiro Shirai, Kenei Furukawa, (unknown), (unknown), (unknown), Yukio Nakabayashi, Tadashi Uwagawa, Toru Ikegami	3
15	The clinical management of peripancreatic fluid collection after distal pancreatectomy 2022 ·Surgery Today ·Masashi Tsunematsu, Yoshihiro Shirai, Ryoga Hamura, Tomohiko Taniai, Mitsuru Yanagaki, Koichiro Haruki, Kenei Furukawa, Shinji Onda, Yoichi Toyama, Takeshi Gocho, Toru Ikegami	3
16	Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection 2022 ·Surgical Oncology ·(unknown), Koichiro Haruki, Tomohiko Taniai, Mitsuru Yanagaki, (unknown), Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, (unknown), Takeshi Gocho, Toru Ikegami	13
17	Living donor liver transplantation for idiopathic portal hypertension with focal nodular hyperplasia 2022 ·SHILAP Revista de lepidopterología ·(unknown), Kenei Furukawa, (unknown), Mitsuru Yanagaki, Koichiro Haruki, Yoshihiro Shirai, Tomohiko Taniai, (unknown), (unknown), Toru Ikegami	1
18	Triple liver hanging maneuver for hepatic central bisectionectomy with caudate lobectomy for resection of huge hepatocellular carcinoma (with video) 2021 ·Surgery Today ·(unknown), Koichiro Haruki, (unknown), Mitsuru Yanagaki, Shinji Onda, Kenei Furukawa, Yoshihiro Shirai, Toru Ikegami	0
19	Risk Factors and Overcoming Strategies of Surgical Site Infection After Hepatectomy for Colorectal Liver Metastases 2021 ·Anticancer Research ·Kenei Furukawa, Shinji Onda, Tomohiko Taniai, Ryoga Hamura, Mitsuru Yanagaki, Masashi Tsunematsu, Koichiro Haruki, Jungo Yasuda, Taro Sakamoto, Takeshi Gocho, Toru Ikegami	5
20	The Significance of the Rapid Turnover Protein Score as a Predictor of the Long-Term Outcomes in Hepatocellular Carcinoma After Hepatic Resection 2021 ·Annals of Surgical Oncology ·Mitsuru Yanagaki, Koichiro Haruki, Jungo Yasuda, Kenei Furukawa, Shinji Onda, Masashi Tsunematsu, Yoshihiro Shirai, Takeshi Gocho, Tomohiko Taniai, Ryoga Hamura, Toru Ikegami	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact